RECEPTOME

Receptome is an asset-centric early-stage therapeutics company that develops products in the immunology, vaccine, and cancer immunotherapy fields. The key focus is on receptors for TNF SuperFamily ligands (TNFSFs) which provide important signals for immunity and tissue regeneration. An additional technology is an alternative to the small molecule STING pathway activators now being developed for cancer immunotherapy. Receptome's strategy is to partner with Pharma or larger biotechs to move its technology into the clinic. The Company's technology is protected by issued and pending patents. Investors are welcomed to power the company's development to the next level.

Also known as: Receptome, LLC

Primary location: La Jolla United States